Sagimet Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$27,876,000 and profit margin reached -1394%. Total operating expenses were $32,740,000.
Profit Margin
| 2019 | 0 | -14.26M | |
|---|---|---|---|
| 2020 | 0 | -11.37M | |
| 2021 | 0 | -24.44M | |
| 2022 | 0 | -30.49M | |
| 2023 | 2M | -27.87M | -1393.8% |
SGMT Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 2M | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 124K | 0 |
Gross profit | 2M | 0 | 0 | -124K | 0 |
Operating exp. | |||||
Research and development | 19.77M | 24.91M | 19.34M | 8.18M | 8.39M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 32.74M | 31.05M | 23.71M | 11.4M | 14.25M |
Operating income | -30.74M | -31.05M | -23.71M | -11.4M | -14.25M |
Other income (expenses), net | 2.86M | 3K | -749K | 30K | -73K |
Income before tax | -27.87M | -30.49M | -24.44M | -11.37M | -14.26M |
Income tax expense | 0 | -31.60M | -23.74M | -176.29K | -9K |
Net income | -27.87M | -30.49M | -24.44M | -11.37M | -14.26M |
Earnings per share | |||||
Basic EPS | -2.66 | -1.38 | -1.1 | -0.51 | -0.64 |
Diluted EPS | -2.66 | -1.38 | -1.1 | -0.51 | -0.64 |
| Data source |